R87.624 Cytologic evidence of malignancy on smear of vagina

Name of the Condition

• Cytologic evidence of malignancy on smear of vagina

Summary

This code indicates the presence of malignant (cancerous) cells detected in a vaginal cytological specimen, such as a Pap smear. The finding suggests abnormal cell growth consistent with malignancy, though further evaluation is typically required to confirm the diagnosis and determine the extent of the disease.

Causes

Malignant cells in vaginal smears may arise from primary vaginal cancer or metastatic spread from other pelvic or distant sites. Common primary causes include squamous cell carcinoma, adenocarcinoma, or melanoma of the vagina. Infections like human papillomavirus (HPV) can also contribute to malignant transformation in some cases.

Risk Factors

• Advanced age
• History of HPV infection
• Prior radiation therapy to the pelvis
• Smoking
• Immunocompromised states (e.g., HIV/AIDS)
• Chronic vaginal irritation or inflammation

Symptoms

Symptoms may include:

• Abnormal vaginal bleeding (e.g., postmenopausal bleeding)
• Unusual vaginal discharge (foul-smelling or bloody)
• Pelvic pain or discomfort
• Vaginal masses or ulcers

Diagnosis

Diagnosis involves cytological testing (e.g., Pap smear) to identify malignant cells, followed by colposcopy, biopsy, or imaging (e.g., MRI, CT) to confirm the diagnosis and assess tumor extent. Additional tests may include HPV typing or tumor marker analysis.

Treatment Options

Treatment depends on the cancer type, stage, and patient health. Options may include:

• Surgery (e.g., vaginectomy, lymph node dissection)
• Radiation therapy
• Chemotherapy
• Targeted therapy or immunotherapy for advanced cases

Prognosis and Follow-Up

Prognosis varies based on cancer stage, type, and treatment response. Early detection improves outcomes. Follow-up typically involves regular monitoring with cytological tests, imaging, and clinical exams to check for recurrence or progression.

Complications

• Local spread to nearby tissues (e.g., bladder, rectum)
• Metastasis to lymph nodes or distant organs
• Treatment-related side effects (e.g., radiation-induced fibrosis, chemotherapy toxicity)
• Sexual dysfunction or vaginal stenosis

Lifestyle & Prevention

• Regular cervical and vaginal cancer screening (e.g., Pap smears, HPV testing)
• HPV vaccination to reduce infection risk
• Smoking cessation
• Safe sexual practices to minimize HPV exposure
• Prompt evaluation of persistent symptoms (e.g., bleeding, discharge)

When to Seek Professional Help

Seek immediate medical attention for:

• Unexplained vaginal bleeding (especially postmenopausal)
• Persistent abnormal discharge
• Pelvic pain or masses
• Unexplained weight loss or fatigue

Tips for Medical Coders

Document the specific type of malignancy (e.g., squamous cell carcinoma) and any associated findings (e.g., metastasis) to support code assignment. Ensure cytological reports clearly indicate malignancy and specify the specimen source (vagina) for accurate coding.